// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Selective fetal growth restriction in monochorionic twins: natural history and a call for classification modification

Hiba J. Mustafa - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Twin–twin transfusion syndrome

N/A

Risk factors for fetal demise in monochorionic twins complicated with selective fetal growth restriction

Hiba J. Mustafa - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Twin–twin transfusion syndrome

N/A

Fetal cardiac intervention in hypoplastic left heart syndrome with intact or restrictive atrial septum

Hiba J. Mustafa - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypoplastic left heart syndrome

N/A

Prenatal agenesis of corpus callosum and diagnostic yield with exome sequencing, systematic review and metanalysis

Hiba J. Mustafa - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Rising trends in perinatal morbidity following trial of labor after cesarean delivery: population-based study

Ali Javinani - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Abnormal neurodevelopment in CDH survivors is not dependent on severity or fetal surgery

Lennart Van der Veeken - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Fetoscopic endoluminal tracheal occlusion balloon-related side effects and their clinical impact

David Basurto - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Consensus protocols for the management of early and late twin-twin-transfusion-syndrome (TTTS), a delphi study

Eyal Krispin - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Twin–twin transfusion syndrome

N/A

Prevalence and risk factors of gestational diabetes in twin pregnancies: population based study

Hiba J. Mustafa - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Gestational Diabetes

N/A

Maternal ethnicity and the risk of fetal myelomeningocele: population based study

Hiba J. Mustafa - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Spina bifida

N/A

Increasing trend of maternal obesity and the risk of fetal myelomeningocele: population based study

Hiba J. Mustafa - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Spina bifida

N/A

Prenatal severe ventriculomegaly and diagnostic yield with exome sequencing, systematic review and meta-analysis

Hiba J. Mustafa - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dandy-Walker syndrome

N/A

Prevalence and risk factors of gestational hypertension and preeclampsia in twin pregnancies: population based study

Hiba J. Mustafa - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Pregnancy-Induced Hypertension

N/A

Diagnostic performance of 32 vs 36 weeks ultrasound predicting late-onset FGR and SGA neonates

Hiba J. Mustafa - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Is low dose aspirin associated with bleeding complications in pregnancy?

Vivienne Souter - Society for Maternal-Fetal Medicine (SMFM) , 2023

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Placenta previa

Aspirin

Sex-stratified Transethnic GWAS Meta-analysis Identifies Novel Candidates For Early Onset Ischemic Stroke

Liisa Tomppo - International Stroke Conference (ISC) , 2023

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Long-term Treatment Risk Of Hemorrhage In Unruptured Brain Arteriovenous Malformation Patients

Helen Kim - International Stroke Conference (ISC) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Vagus Nerve Stimulation (VNS) Paired With Upper Extremity Rehabilitation In Chronic Stroke: Improvements In Wrist And Hand Impairment And Function

Teresa J Kimberley - International Stroke Conference (ISC) , 2023

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Association Between Use Of A Flying Intervention Team Versus Patient Interhospital Transfer And Longterm Clinical Outcome Among Patients With Acute Ischemic Stroke And Large Vessel Occlusion In Non-urban Germany

Nikolai Hubert - International Stroke Conference (ISC) , 2023

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Large-scale Reliability/Validity Assessments And Quantification Of Cognition Within The Imperial College Comprehensive Assessment For Cerebrovascular Disease (IC3): A Novel In-depth, Self-administered, Online Cognitive Tool

Dragos C Gruia - International Stroke Conference (ISC) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved